SurePrint G3 Human CGH+SNP Microarray Platform is a chromosomal aberration detection platform that can simultaneously detect copy number variations and copy-neutral variations.
The Agilent SurePrint G3 Human CGH+SNP Microarray Platform extends the capabilities of the standard CGH platform to allow the simultaneous detection of copy number variations (CNVs) and copy-neutral chromosomal changes, such as loss of heterozygosity (LOH) and uniparental disomy (UPD). This is achieved by adding a set of SNP probes to the array and utilizing data analysis within Agilent's Genomic Workbench software.
The sample preparation process can start with as little as 500 ng of DNA.
The platform provides approximately 5–10 Mb resolution for detecting copy-neutral LOH or UPD.
With high-quality DNA samples, the SNP call rate is greater than 95% with a greater than 99% accuracy.